CEOInterviews.AI
Start App
Try: AI strategy tariffs earnings guidance layoffs interest rates growth

Jeffrey Tangney

Co-Founder, Chief Executive Officer & Chairperson, DOXIMITY INC

Search every verified Jeffrey Tangney interview, podcast appearance, and on-the-record quote — each transcript cross-checked by AI and human review to confirm speaker identity. Jeffrey Tangney, co-founder and CEO of Doximity, discussed the company's fiscal 2027 first quarter results on an earnings call, reporting revenue of $156.6 million, a 7% increase year-over-year, and noting that the company raised its full-year outlook. He highlighted Doximity's continued investment in clinical AI, stating that the company is "leaning in" on what he described as a "once in a generation opportunity" to build an AI-driven future for medicine. Tangney also cited third-party evaluations, saying that Doximity's Ask product led among U.S. models in clinical error rates and safety ratings, as referenced by Fortune magazine. Tangney also discussed the company's evolving advertising business, noting that Doximity is testing new ad formats and therapeutic area categories ahead of the "upfronts," with a focus on securing larger, longer-term contracts. He drew a comparison to the evolution of auction-based digital advertising, suggesting that a similar shift in healthcare marketing could represent a significant future opportunity for the company. In earlier remarks from a May 2025 earnings call, Tangney reported record free cash flow of $107 million for the fourth quarter and a 13% increase in annual revenue to $645 million, while also announcing the addition of e-prescribing capabilities to the platform and the expansion of AI tools used by nearly half of U.S. physicians.

Recent appearances

The summary and quote tags on this profile are produced with AI assistance from verified, first-person interview transcripts, then checked by our team to confirm the speaker's identity and the accuracy of every quote. See how we verify →